Related Experiment Video
Updated: Jul 4, 2026

Microvascular Embolism Mouse Model for In Vivo Two-photon Microscopy Using Fluorescent Polystyrene Microspheres
Published on: November 21, 2025
The complications of cardioembolic stroke: lessons from the VISTA database
Hen Hallevi1, Karen C Albright, Sheryl Martin-Schild
1University of Texas at Houston, Vascular Neurology Program, Houston, Tex. 77030, USA. hen.hallevi@uth.tmc.edu
Insights
Cardioembolic stroke (CES) complications include stroke progression, bleeding, and hemorrhagic transformation (HT). Stroke progression was the most frequent serious complication, with a high mortality rate observed in this patient cohort.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Stroke Research
Background:
- Cardioembolic stroke (CES) represents a significant portion of ischemic stroke cases.
- Understanding CES complications is crucial for patient management and outcomes.
Purpose of the Study:
- To describe the spectrum of complications in patients with cardioembolic stroke.
- To analyze the incidence and patterns of complications in a non-thrombolytic cohort.
Main Methods:
- Analysis of a cohort of CES patients from the VISTA database.
- Inclusion criteria focused on patients not receiving thrombolytic therapy.
Main Results:
- Recurrent stroke (2.5%), stroke progression (7.8%), systemic bleeding (3%), and hemorrhagic transformation (HT) (1.5%) were observed.
- HT exhibited a bimodal temporal distribution.
- Mortality rate was 25.9%, associated with stroke progression and recurrence.
Conclusions:
- Hemorrhagic transformation is a common complication in CES patients, presenting with a bimodal pattern.
- Stroke progression emerged as the most frequent and serious complication.
- Further research is needed to identify predictors of stroke progression in CES.
Background:
Cardioembolic stroke (CES) accounts for 20-30% of ischemic strokes. We attempted to describe the complications of CES.
Methods:
We analyzed a cohort of CES patients from the VISTA database who were not given thrombolytics.
Results:
397 patients were included. Recurrent stroke occurred in 2.5% (10/397); stroke progression in 7.8% (31/397); systemic bleeding in 3% (12/397), and hemorrhagic transformation (HT) in 1.5% (6/397). A bimodal temporal distribution was observed for HT. The mortality rate was 103/397 (25.9%) and was associated with stroke progression and recurrence.
Conclusions:
HT is common in CES patients and presents in a bimodal distribution. Stroke progression is the most frequent serious complication. Further study is indicated to identify predictors of stroke progression.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction